R&D
Health Innovators - Steve Damon
The hypodermic needle was invented in 1844 by Francis Rynd and, while …
19704 items found
News
Third Arc's $165m for T cell engagers, plus other bio rounds
This week's round-up of new financings in the biotech world is headed …
Sales & Marketing
Creative review: The Cannes Lions trends that pharma needs to know about
Pharma creative needs to stand up and be counted. That’s the message …
News
AZ joins call for new UK PM to back Oxford-Cambridge hub
In a letter to the new UK Prime Minister Keir Starmer, leading …
R&D
5 strategies for biopharma to optimise patient recruitment in clinical trials
Patient recruitment remains a significant challenge for biopharma …
News
Pfizer's haemophilia B gene therapy gets EU green light
There will soon be two gene therapies available for patients with …
News
Shingles shot could be a simple way to delay dementia
Vaccination with GSK's recombinant shingles vaccine, Shingrix, could …
News
ODAC unpicks AZ's Imfinzi trial in perioperative NSCLC
FDA reviewers were so frustrated by AstraZeneca's application for …
Patients
Sponsored
Patient engagement throughout the product life cycle
One of the things that makes patient engagement for pharma companies …
News
Ipsen builds again, licensing Day One glioma drug
Ipsen has signed yet another portfolio-expanding deal – its fifth of …
R&D
Ageing Europe - It’s time we prioritised neurological conditions
Europeans are living longer than ever before – tangible proof of the …
News
European big pharmas raise guidance on stronger sales
AstraZeneca, Roche, and Sanofi released their second-quarter results …
News
Seaport docks $225m for its improved neuropsychiatry drugs
After emerging from the shadows with a $100 million Series A in April, Seaport Therapeutics has moved swiftly to shore up its finances with a $225 million second round to fund the developme
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
R&D
Partner Content
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
